Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study
Titel:
Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study
Auteur:
Pavlovsky, Santiago Corrado, Claudia Pavlovsky, Miguel A. Prates, María V. Zoppegno, Lucía Giunta, Mario Cerutti, Ider Palomino, Elsa Pagani, Fernando Lastiri, Francisco Bar, Daniel Bezares, Raimundo F. Avila, Graciela